Month: <span>April 2017</span>

Home / 2017 / April
Post

Antibody is effective against radiation-induced pulmonary fibrosis

Radiation therapy is part of the treatment regimen for about two thirds of cancer patients today. Radiotherapy is well tolerated in most cases, but it can also lead to damage in healthy tissues that are also irradiated. One debilitating side effect is radiation-induced fibrosis. Fibrosis is a process of scarring by which healthy tissue is...

Post

Scientists find surprising impact of junk DNA and RNA in cancer

Killer T cells surround a cancer cell.   “Human satellite II,” an exceptionally high-copy but unexplored sequence of the human genome thought of as “junk DNA,” has a surprising ability to impact master regulators of our genome, and it goes awry in 50 percent of tumors, according to a new study published in Cell Reports by scientists...

Post

New molecules may offer treatment option for some aggressive prostate cancers

Micrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer)    Novel molecules called selective androgen receptor degraders (SARDs) may offer the next generation of treatment options for advanced prostate cancer, a new industry-sponsored study reports. The results of this research will be presented Saturday, April 1, at ENDO 2017, the 99th annual...